MV Capital Management Inc. Acquires 276 Shares of HCA Healthcare, Inc. $HCA

MV Capital Management Inc. lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 138.7% in the 2nd quarter, Holdings Channel.com reports. The firm owned 475 shares of the company’s stock after acquiring an additional 276 shares during the quarter. MV Capital Management Inc.’s holdings in HCA Healthcare were worth $182,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. ORG Partners LLC lifted its stake in shares of HCA Healthcare by 27.9% during the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares during the last quarter. Avantax Advisory Services Inc. increased its position in HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock valued at $2,791,000 after buying an additional 32 shares in the last quarter. Glenview Trust co raised its position in shares of HCA Healthcare by 2.3% in the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock valued at $501,000 after purchasing an additional 32 shares during the last quarter. Horizon Investments LLC increased its stake in HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares in the last quarter. Finally, Sivia Capital Partners LLC grew its holdings in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $474.08 on Thursday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $479.43. The company has a market cap of $108.18 billion, a price-to-earnings ratio of 18.33, a PEG ratio of 1.38 and a beta of 1.41. The business’s 50 day moving average price is $431.29 and its 200 day moving average price is $394.54.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Analyst Ratings Changes

Several research firms have weighed in on HCA. Wolfe Research downgraded HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Royal Bank Of Canada boosted their target price on shares of HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. KeyCorp boosted their price objective on HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Finally, Cowen restated a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $473.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.